Literature DB >> 17693186

Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.

Gemma Armengol1, Saad Eissa, Juan José Lozano, Sohair Shoman, Lauro Sumoy, María Rosa Caballín, Sakari Knuutila.   

Abstract

Carcinoma of the urinary bladder is the most common malignancy in many tropical and subtropical countries due to endemic infection by Schistosoma hematobium (bilharzia). In the current study, we performed a high-resolution analysis of gene copy number amplifications using array comparative genomic hybridization to compare DNA copy number changes in pools of Schistosoma-associated (SA) and non-Schistosoma-associated (NSA) bladder cancer (BC). Many DNA copy number changes were detected in all studies, with multiple gains and losses of genetic material. The most frequent alterations were gains on 5p15.2 approximately p15.33, 8q13.1, and 11q13, and losses on 8p21.3 approximately p22 and 22q13. Even when SA pools showed no Schistosoma-specific gene copy number profiling as compared to NSA pools, some genes seemed to be gained (ELN on 7q11.23) and some lost (PRKAG3 on 2q35 and PRDM6 on 5q23.2) in SA-SCC. The following genes were gained in all histopathologic categories: SRC (20q11.23), CEBPB (20q13.13), and GPR9 (Xq13.1). Our study did not provide clear evidence of differences in carcinogenesis of SA-BC and NSA-BC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693186     DOI: 10.1016/j.cancergencyto.2007.04.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder.

Authors:  Hongkun Wang; Ying Wang; Krishna K Kota; Bing Sun; Bhaskar Kallakury; Nabiel N Mikhail; Douaa Sayed; Ahmed Mokhtar; Doaa Maximous; Etemad H Yassin; Scarlett X Sun; Xiaofei Chen; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

2.  Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A.

Authors:  Jianhua Lu; Weikai Chen; Hao Liu; Huilin Yang; Tao Liu
Journal:  J Clin Lab Anal       Date:  2019-07-31       Impact factor: 2.352

Review 3.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.